Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in Type I diabetic patients

被引:25
|
作者
Tarnow, L [1 ]
Kjeld, T [1 ]
Knudsen, E [1 ]
Major-Pedersen, A [1 ]
Parving, HH [1 ]
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
关键词
renin-angiotensin system genes; glycaemic control; diabetic nephropathy; Type I diabetes;
D O I
10.1007/s001250051377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Reports on a putative synergism between poor glycaemic control and carriage of the angiotensin II type 1 receptor (AGTR1) C-1166-allele and risk of diabetic nephropathy have been conflicting. Therefore, we investigated the interaction between long-term glycaemic control and three polymorphisms in the genes coding for AGTR1 (A(1166)-->C), angiotensin converting enzyme (ACE/ ID) and angiotensinogen (M235T) on risk of developing diabetic nephropathy. Furthermore, we investigated the relation between a random measurement and long-term measurements of haemoglobin A(1c) (HbA(1c)). Methods. We studied Caucasian patients with Type I (insulin-dependent) diabetes mellitus and nephropathy (120 men 74 women, age 41.1 +/- 9.6 years, diabetes duration 28 +/- 8 years) and long-standing Type I diabetic patients with persistent normoalbuminuria (112 men 69 women, age 42.5 +/- 10.0 years, diabetes duration 27 +/- 9 years). Genotyping was PCR-based and metabolic control estimated from all measurements of HbA(1c) done in each patient [average (range) n = 31 (6-74)]. The median observation time (range) was 13.5 (2-14) years. Results. Type I diabetic patients with a history of poor glycaemic control (HbA(1c) above the median, 8.7%) had an increased risk of diabetic nephropathy compared with patients with a better metabolic control, OR (95% CI): 9.2 (5.8-14.7). The magnitude of this risk was similar in carriers and non-carriers of the mutations. The risk of nephropathy in patients with HbA(1c) above compared with below the median in carriers of the mutant C-1166-allele, D-allele, or T235-allele were 7.6 (95% CI: 3.9-14.8), 10.4 (6.0-17.8) and 9.8 (5.4-17.9), respectively. A significant correlation (r = 0.74, p < 0.001) existed between a random and long-term measurements of HbA(1c) with a small mean difference (limits of agreement) [0.2 (-1.8 to 2.1) %] between the two estimates. Conclusian/interpretation. Poor metabolic control is a major risk factor for diabetic nephropathy in Caucasian Type I diabetic patients. This risk was similar in carriers and non-carriers of the mutant alleles of the AGTR1(A(1166)-->C), ACE/ID and angiotensinogen-M235T polymorphisms. The HbA(1c) value measured at random reflects rather closely average long-term KbA(1c) values.
引用
收藏
页码:794 / 799
页数:6
相关论文
共 47 条
  • [1] Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in Type I diabetic patients
    L. Tarnow
    T. Kjeld
    E. Knudsen
    A. Major-Pedersen
    H. -H. Parving
    Diabetologia, 2000, 43 : 794 - 799
  • [2] Lack of synergism between poor glycaemic control and renin angiotensin system genes on risk of diabetic nephropathy in type 1 diabetic patients
    Tarnow, L
    Kjeld, T
    Knudsen, E
    Major-Pedersen, A
    Parving, HH
    DIABETOLOGIA, 2000, 43 : A13 - A13
  • [4] Comments to:: !Tarnow L, !Kjeld T, !Knudsen E et al. (2000) Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in Type I diabetic patients.: Diabetologia 43: 794-799
    Soltész, G
    Rózsai, B
    DIABETOLOGIA, 2001, 44 (04) : 520 - 520
  • [5] Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control
    Savage, DA
    Feeney, SA
    Fogarty, DG
    Maxwell, AP
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (04) : 891 - 894
  • [6] Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients
    Fradin, S
    Goulet-Salmon, B
    Chantepie, M
    Grandhomme, F
    Morello, R
    Jauzac, P
    Reznik, Y
    DIABETES & METABOLISM, 2002, 28 (01) : 27 - 32
  • [7] Renin Angiotensin Aldosterone System Gene Polymorphisms among Type 2 Diabetic Patients with Retinopathy and Nephropathy
    Pawar, Vaishali S.
    Datkhile, Kailas D.
    Sontakke, Ajit V.
    Pawar, Satyajeet K.
    Patil, Prajakta S.
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2024, 16 (SUPPL 5) : S4660 - S4666
  • [8] Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy
    Wong, TYH
    Szeto, CC
    Chow, KM
    Chan, JCN
    Li, PKT
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (01) : 9 - 17
  • [9] Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein ε, lipoprotein lipase and cholesteryl ester transfer protein
    Hadjadj, S
    Gallois, Y
    Simard, G
    Bouhanick, B
    Passa, P
    Grimaldi, A
    Drouin, P
    Tichet, J
    Marre, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (12) : 1971 - 1976
  • [10] Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients
    Arfa, Imen
    Abid, Abdelmajid
    Nouira, Sonia
    Elloumi-Zghal, Houda
    Malouche, Dhafer
    Mannai, Imen
    Zorgati, Mohamed Majdi
    Ben Alaya, Nissaf
    Rebai, Ahmed
    Zouari, Bechir
    Ben Ammar, Slim
    Ben Rayana, Mohamed Chiheb
    Hmida, Slama
    Blousa-Chabchoub, Samira
    Abdelhak, Sonia
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2008, 9 (01) : 32 - 36